Table 4.
Association of serum bicarbonate with cognitive function domains in the SPRINT MIND MRI subgroup
Model 1, n=681 | Model 2, n=681 | Model 3, n=594 | ||||
---|---|---|---|---|---|---|
Domain | Estimate (SEM) | P Value | Estimate (SEM) | P Value | Estimate (SEM) | P Value |
Global cognitive function | 0.0391 (0.01) | 0.001 | 0.0358 (0.01) | 0.003 | 0.0328 (0.01) | 0.01 |
Executive function | 0.0304 (0.01) | 0.02 | 0.0246 (0.01) | 0.06 | 0.0246 (0.01) | 0.07 |
Memory | 0.0255 (0.01) | 0.05 | 0.0256 (0.01) | 0.05 | 0.0203 (0.01) | 0.14 |
Attention/concentration | 0.0240 (0.01) | 0.07 | 0.0196 (0.01) | 0.15 | 0.0164 (0.01) | 0.26 |
Language | 0.0024 (0.01) | 0.86 | −0.0005 (0.01) | 0.97 | 0.0078 (0.01) | 0.59 |
Model 1 adjusted for age, network, education, sex, race, cardiovascular disease, systolic BP, use of diuretics and antiacidosis medications (sodium bicarbonate, sodium citrate, citric acid/sodium citrate), eGFR, and log-transformed urine albuminuria. Model 2 adjusted for model 1 components as well as scanner type, intracranial volume, and total abnormal volume. Model 3 adjusted for model 2 components as well as vascular reactivity and cerebral blood flow.